Evidence map›Paper›PMID 35225394›Full record

ArticleIndoor air2022

Dispersion of SARS-CoV-2 in air surrounding COVID-19-infected individuals with mild symptoms.

Jostein Gohli, Ane Marie Anderson, Arne Broch Brantsaeter, Kari Oline Bøifot, Carola Grub, Cathrine Lund Hadley, Andreas Lind, Ellen Susanne Pettersen, Arne Vasli Lund Søraas, Marius Dybwad

Abstract read
In one paragraph

Article in Indoor air, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jostein GohliNorwegian Defence Research Establishment, Kjeller, Norway.ORCID 0000-0002-7273-1860
Ane Marie AndersonOslo University Hospital, Nydalen, Norway.
Arne Broch BrantsaeterDepartment of Infectious Diseases, Norwegian National Unit for CBRNE Medicine, Oslo University Hospital, Nydalen, Norway.
Kari Oline BøifotNorwegian Defence Research Establishment, Kjeller, Norway.
Carola GrubInstitute of microbiology, Norwegian Armed Forces Joint Medical Services, Kjeller, Norway.
Cathrine Lund HadleyOslo University Hospital, Nydalen, Norway.
Andreas LindOslo University Hospital, Nydalen, Norway.
Ellen Susanne PettersenOslo University Hospital, Nydalen, Norway.
Arne Vasli Lund SøraasOslo University Hospital, Nydalen, Norway.
Marius DybwadNorwegian Defence Research Establishment, Kjeller, Norway.

Funding

Norwegian Research Council 312688
6 · The paper itself

Abstract

Since the beginning of the pandemic, the transmission modes of SARS-CoV-2-particularly the role of aerosol transmission-have been much debated. Accumulating evidence suggests that SARS-CoV-2 can be transmitted by aerosols, and not only via larger respiratory droplets. In this study, we quantified SARS-CoV-2 in air surrounding 14 test subjects in a controlled setting. All subjects had SARS-CoV-2 infection confirmed by a recent positive PCR test and had mild symptoms when included in the study. RT-PCR and cell culture analyses were performed on air samples collected at distances of one, two, and four meters from test subjects. Oronasopharyngeal samples were taken from consenting test subjects and analyzed by RT-PCR. Additionally, total aerosol particles were quantified during air sampling trials. Air viral concentrations at one-meter distance were significantly correlated with both viral loads in the upper airways, mild coughing, and fever. One sample collected at four-meter distance was RT-PCR positive. No samples were successfully cultured. The results reported here have potential application for SARS-CoV-2 detection and monitoring schemes, and for increasing our understanding of SARS-CoV-2 transmission dynamics. Practical implications. In this study, quantification of SARS-CoV-2 in air was performed around infected persons with mild symptoms. Such persons may go longer before they are diagnosed and may thus be a disproportionately important epidemiological group. By correlating viral concentrations in air with behavior and symptoms, we identify potential risk factors for viral dissemination in indoor environments. We also show that quantification of total aerosol particles is not a useful strategy for monitoring SARS-CoV-2 in indoor environments.

Indexed as

Air MicrobiologyAir Pollution, IndoorCOVID-19AerosolsHumansPandemicsSARS-CoV-2Aerosolsaerosolcell culturecoronavirusCOVID-19RT-PCRSARS-CoV-2

Identifiers

PMID35225394
PMCPMC9111593

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.